Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Qiagen Stock Tanks in December, Fluidigm Shares Soar as GenomeWeb Index Ends 2019 on High Note

Qiagen Stock Tanks in December, Fluidigm Shares Soar as GenomeWeb Index Ends 2019 on High Note

Jan 02, 2020
|
staff reporter

NEW YORK – The GenomeWeb Index rose more than 3 percent in December, and saw November's top gainer and top decliner switch places.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Suit and Settlement

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

CRUK Announces Cuts

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Long Wait

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

PNAS Papers on Ancient European Migrations, Triple-Negative Breast Cancer Fusions, More

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.

What's Popular?

In Business News

  1. FDA Issues Emergency Use Authorization for Viracor Eurofins Coronavirus LDT

  2. Coronavirus Pandemic Expected to Significantly Disrupt Hologic Q2 Revenues

  3. FDA Issues Emergency Use Authorization for Gnomegen Coronavirus Test

  4. NanoString Preliminary Q1 Revenues Take Hit From COVID-19, Firm Withdraws 2020 Guidance

  5. Thermo Fisher Preliminary Q1 Revenues up 1 to 2 Percent; Firm Withdraws 2020 Guidance

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.